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SUMMARY
Nowadays, orthotopic liver transplatation is an accepted tlerapeutic possib-
ility for non-curable end-stage liver diseases. Despite 1fos impressive irnprove-
ments achieved within thirly years of liver llanqplantation the procedure is
still accompanied by serious complications. One of the complications is graft
rejection. Similar to other organ grafts the liver graft is also subject to the
host's alloresponse although the liver tends to be less vividly rejected as
compared with the kidney graft. Hyperacute rejection is either non-existent or
extremely rare although the liver is regularly transplanted between HI-A nis-
matched individuals. Acute rejection is a regularly present especially in the
fust months after transplantation. In most cases this complication responds
well to treatment. The prognosis of chronic rejection is less favourable because
sofar anti rejection treatment does not seem to influence the course leaving
retransplantation as the only therapeutic possibility.
This thesis is focussed upon graft rejection, based on studies on serial graft
biopsies. Biopsy monitoring of the transpla:rted liver has provon to be a safe
and accurate diagnostic aid.
In chapter I the morphology of acute rejection in biopsies of liver allo-
grafts obtained in the fust two weeks after llansplantation (1\) was analyzed.
Material from patients maintained on conventional immunosuppressive therapy
consisting of azathioprine and prednisone (AZA, Groningen) was compared to
that of patients receiving cyclosporine A and prednisone (with or without aza-
thioprine) in low doses (CSA, Minneapolis). Follow up biopsies ranged from 3
weeks to one year after Tx. Time zero biopsies and/or pretransplant biopsies
served as baseline histology. Our data revealed an identical morphologic picture
during acute rejection early after Tx in both patient groups except for a more
marked degree of venous endothelialitis and hepatocyte fxllssning in the
Minnesota material. The follow up biopsies suggested a spontaneous resolution
of these early rejection episodes without anti rejection treatment in 6 of the
10 AZA patients. No ffierences in the long term survival rate between the
CSA and AZA fieated patients were observed.
The study in chapter II documents MHC Class I and II e4pression during
early acute rejection of human liver grafts. Serial graft biopsies were studied.
10 patients received azathioprine (AZA) and prednisone; 6 patients were treated
with quadruple therapy (azathioprine, cyclosporine A, prednisone and cyclophos-
phamide). To study the specificity of changes in MHC antigen-expression,
biopsies of 6 patients with min61 s1 no morphological abnormalities served as
controls. In addition, phenotlpes of inflammatory cells present during rejection
were analyzed using a panel of monoclonal antibodies.
Our results show that during acute rejection elpression of MHC Class I and II
antigens increased significantly in both the AZ,A treated patieDts and those
treated with quadruple therapy, i1 3 similu pattern. There was enhanced MHC
Class I expression on hepatocytes, bile duct epithelium and sinusoidal endothel-
ium, and Class II antigen on Kupffer cells and sinusoidal endothelium. Bile duct
epithelium was consistently positive for Class II antigen; no significant difference
with the non-rejection group was observed. T cells are the predominant inflamm-
atory cells during rejection with equal quantities of CD4+ and CDS+ cells. A
majority of the infiltrating T cells shows e4pression of Class II antigen but
does not react with anti Interleukin-2 receptor antibody. This may be the
result of immgaosuppressive therapy or a simple reflection of the temporary
expression of Interleukin-2 receptors during lymphocyte activation.We hypo-
thesized that the induction of MHC antigens on bile duct epitheliu'n preludes
to rejection whereas the elpression on hepatocytes represents an epiphenomenon.
The disappearance of certain cell populations of donor origin and their
replacement by recipient-specific cells constitutes a possible e4planation for
the relatively mild course of acute rejection despite lack of MHC compatibility
in humau orthotopic liver transplantations. In chapter III, graft biopsies of 12
OLT patients from a total of 42 patients were studied for e4pression of MHC
antigens after transplantation gsing monoclonal antibodies to HI-A-ABC and
HLA-DR. The patients were selected based upon donor-recipient misxmtshing
for HLA-A2,87,Drw52, or DQw1. Monoclonal antibodies to these 4 polymorphic
HI-A antigens and monoclonal antibodies to HI-A-ABC and -DR were applied to
frozen tissue sections and visualized gsing an immunspsl6xidase gsshnique.
Expression of HI-A-ABC and -DR on, respectively, hepatocytes and bile duct
epitheli"- were observed in posttransplant gaft conditions such as viral
infections, cholangitis, and acute rejection. However, no specific pattern of
MHC antigen distribution was observed for these various pathological graft
conditions.
Disappearance of DR-positive Kupffer cells of donor origin and immi-
gration of recipient ones was encountered in the eady posttransplant biopsies.
This Kupffer cell replacement coincided with a reversible episode of acute
rejection. The disappearance of highly immunegsnic cellular somponents as
HLA-DR positive Kupffer cells of graft origin may be one of the mechanisms
contributing to the mild rejection response observed in human liver transplanta-
tion.
In chapter IV four cases of chronic rejection were selected from a total
of 48 patients who underwent orthoptic liver transplantation h Groningen from
1979 to L985. The histopathologic changes in these endstage livers (rwo removed
at ReTx, two at autopsy) consisted of obliterative arterial vasculopathy with
intimd fibrosis and subintimal accumulation of lipidJaden macrophages ("foam
cells"), sinusoidal foa- cells, portal enlargement with fibrosis, severe cholestasis,
and a decreased number of portal bile ducts with damage o115s lsnaining and
larger ones. Comparison of percutaneous serial graft biopsies from each of these
four cases obtained before and L, 3 to 4, and 6 to 8 weeks following OLT (a
total of 16 biopsies) with time-matched biopsies of six cases with SO (22
biopsies) did not reveal morphologic differences between both groups, except
for the appearance of sinusoidal foam cells in three of the four cases with
ultimate CR. It is concluded that sofar, no predictive histologic features are
available for chronic rejection.
The pathogenetic mechanisms of chronic liver allograft rejection is un-
known. Recent studies reported the influence of lymphocytotoxic antibodies and
HLA mismstghing on the development of chronic rejection.
In chapter V the influence of these two factors are investigated in 9
patients with chronic rejection out of 83 orthotopic liver transplantations. The
results of this study show that patients with a positive llmphocytotoxic cross-
match due to donor specific antibodies are significantly more likely to develop
chronic rejection while HLA-DR mismatch also seem to be a contributary factor.
It is hypothesized that host anti-idiotypic antibodies might be an important aid
in the defense against the development of chronic rejection.
In the general discussion, finally, the findings in the foregoing chapters
are discussed in the context of the 3 phases of alloresponse: alloantigen present-
ation and recognition, T cell activation and generation of effector cells and
graft destruction.
